Loading...

TYRA TYRA BIOSCIENCES INC Management Changes 8-K Filing

TYR

TYR

TYRA BIOSCIENCES INC

(TYRA)

2026 8-K

Financial Results

Board Appointment

Management Change

Financial Results Announced

Management Change

Financial Results Announcement

Clinical Study Update

Financial Results Report

Product Expansion

Financial Statements

Financial Results

Financial Results

Director Resignation

Equity Exchange

Financial Results Announcement

Annual Meeting and Liabilit...

Financial Results Announcement

Appointment of Directors

Earnings Reports

Private Placement

FDA Designation for TYRA-30...

Initiation of SURF201 Phase...

Earnings Reports

Amended and Restated Bylaws

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Incentive Plan Adoption and...

External Links:

On April 1, 2026, Tyra Biosciences appointed Julia Rueb as its principal accounting officer, succeeding Alan Fuhrman, who remains the Chief Financial Officer. Julia Rueb has been with the company since January 2024 and has extensive experience in finance and accounting in the life sciences sector.

AI Assistant

TYRA BIOSCIENCES INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.